SPY328.92+0.13 0.04%
DIA267.04+0.32 0.12%
IXIC10,911.45+8.65 0.08%

Goldman Sachs Maintains Buy on Karuna Therapeutics, Raises Price Target to $109

Goldman Sachs maintains Karuna Therapeutics (NASDAQ:KRTX) with a Buy and raises the price target from $35 to $109.

Benzinga · -

Goldman Sachs maintains Karuna Therapeutics (NASDAQ:KRTX) with a Buy and raises the price target from $35 to $109.